Sanli Pharmaceutical (603439.SH) plans to raise no more than 700 million yuan through a private placement.

Smart Finance APP News, Sanli Pharmaceutical (603439.SH) announced that the company plans to issue A shares to specific object Guizhou Cenli Technology Co., Ltd. (referred to as "Cenli Technology," to be established) in cash for the subscription of the company's shares. As of the announcement of this plan, Cenli Technology (to be established) is 100% owned by the company's controlling shareholder and actual controller, Zhang Hai.